Frequent loss of expression of the pro-apoptotic protein Bim in renal cell carcinoma: Evidence for contribution to apoptosis resistance

Oncogene

Volumn 26, Issue 49, 2007, Pages 7038-7048

  Zantl, N ^a   Weirich, G ^a   Zall, H ^a   Seiffert, B M ^a   Fischer, S F ^a,c   Kirschnek, S ^a   Hartmann, C ^a   Fritsch, R M ^a   Gillissen, B ^b   Daniel, P T ^b   Hacker G ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Apoptosis; Bcl 2; Bim; Expression; Renal cell carcinoma

Indexed keywords

BIM PROTEIN; DOXORUBICIN; HISTONE; PROTEIN; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN MCL 1; PROTEIN NOXA; PROTEIN P53; PROTEIN PUMA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER RESISTANCE; CHEMOSENSITIVITY; CONTROLLED STUDY; DEACETYLATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

ADENOVIRIDAE; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; BLOTTING, WESTERN; CARCINOMA, RENAL CELL; DOWN-REGULATION; DOXORUBICIN; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN G; KIDNEY NEOPLASMS; MEMBRANE PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RABBITS; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 35548967197     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210510     Document Type: Article

References (53)

1. Adams JM, Cory S. (2001). Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci 26: 61-66.
2. Bird AP, Wolffe AP. (1999). Methylation-induced repression - belts, braces, and chromatin. Cell 99: 451-454.
3. Bouillet P, Metcalf D, Huang DC, Tarlinton DM, Kay TW, Kontgen F et al. (1999). Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286: 1735-1738.
4. Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, Hinds MG et al. (2005). Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 17: 393-403.
5. Coultas L, Bouillet P, Loveland KL, Meachem S, Perlman H, Adams JM et al. (2005). Concomitant loss of proapoptotic BH3-only Bcl-2 antagonists Bik and Bim arrests spermatogenesis. EMBO J 24: 3963-3973.
6. Coultas L, Bouillet P, Stanley EG, Brodnicki TC, Adams JM, Strasser A. (2004). Proapoptotic BH3-only Bcl-2 family member Bik/Blk/Nbk is expressed in hemopoietic and endothelial cells but is redundant for their programmed death. Mol Cell Biol 24: 1570-1581.
7. Daniel PT, Pun KT, Ritschel S, Sturm I, Holler J, Dorken B et al. (1999). Expression of the death gene Bik/Nbk promotes sensitivity to drug-induced apoptosis in corticosteroid-resistant T-cell lymphoma and prevents tumor growth in severe combined immunodeficient mice. Blood 94: 1100-1107.
8. Debatin KM, Poncet D, Kroemer G. (2002). Chemotherapy: targeting the mitochondrial cell death pathway. Oncogene 21: 8786-8803.
9. Dijkers PF, Medema RH, Lammers JW, Koenderman L, Coffer PJ. (2000). Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1. Curr Biol 10: 1201-1204.
10. Earnshaw WC, Martins LM, Kaufmann SH. (1999). Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 68: 383-424.
11. Egle A, Harris AW, Bouillet P, Cory S. (2004). Bim is a suppressor of Myc-induced mouse B cell leukemia. Proc Natl Acad Sci USA 101: 6164-6169.
12. Fischer SF, Schwarz C, Vier J, Hacker G. (2001). Characterization of antiapoptotic activities of Chlamydia pneumoniae in human cells. Infect Immun 69: 7121-7129.
13. Fischer SF, Vier J, Kirschnek S, Klos A, Hess S, Ying S et al. (2004). Chlamydia inhibit host cell apoptosis by degradation of proapoptotic BH3-only proteins. J Exp Med 200: 905-916.
14. Gerhard MC, Zantl N, Weirich G, Schliep S, Seiffert B, Hacker G. (2003). Functional evaluation of the apoptosome in renal cell carcinoma. Br J Cancer 89: 2147-2154.
15. Gillissen B, Essmann F, Graupner V, Starck L, Radetzki S, Dorken B et al. (2003). Induction of cell death by the BH3-only Bcl-2 homolog Nbk/Bik is mediated by an entirely Bax-dependent mitochondrial pathway. EMBO J 22: 3580-3590.
16. Green DR, Evan GI. (2002). A matter of life and death. Cancer Cell 1: 19-30.
17. Green DR, Reed JC. (1998). Mitochondria and apoptosis. Science 281: 1309-1312.
18. Gurova KV, Hill JE, Guo C, Prokvolit A, Burdelya LG, Samoylova E et al. (2005). Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-kappaB-dependent mechanism of p53 suppression in tumors. Proc Natl Acad Sci USA 102: 17448-17453.
19. Gurova KV, Hill JE, Razorenova OV, Chumakov PM, Gudkov AV. (2004). p53 pathway in renal cell carcinoma is repressed by a dominant mechanism. Cancer Res 64: 1951-1958.
20. Han J, Flemington C, Houghton AB, Gu Z, Zambetti GP, Lutz RJ et al. (2001). Expression of bbc3, a pro-apoptotic BH3-only gene, is regulated by diverse cell death and survival signals. Proc Natl Acad Sci USA 98: 11318-11323.
21. Hanahan D, Weinberg RA. (2000). The hallmarks of cancer. Cell 100: 57-70.
22. Hengartner MO. (2000). The biochemistry of apoptosis. Nature 407: 770-776.
23. Huang A, Fone PD, Gandour-Edwards R, White RW, Low RK. (1999). Immunohistochemical analysis of BCL-2 protein expression in renal cell carcinoma. J Urol 162: 610-613.
24. Janzen NK, Kim HL, Figlin RA, Belldegrun AS. (2003). Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am 30: 843-852.
25. Jeffers JR, Parganas E, Lee Y, Yang C, Wang J, Brennan J et al. (2003). Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 4: 321-328.
26. Kallio JP, Hirvikoski P, Helin H, Luukkaala T, Tammela TL, Kellokumpu-Lehtinen P et al. (2004). Renal cell carcinoma Mib-1, Bax and Bcl-2 expression and prognosis. J Urol 172: 2158-2161.
27. Kane RC, Farrell AT, Saber H, Tang S, Williams G, Jee JM et al. (2006). Sorafenib for the treatment of advanced renal cell carcinoma. Clin Cancer Res 12: 7271-7278.
28. Kim H, Rafiuddin-Shah M, Tu HC, Jeffers JR, Zambetti GP, Hsieh JJ et al. (2006). Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies. Nat Cell Biol 8: 1348-1358.
29. Kolenko V, Uzzo RG, Bukowski R, Bander NH, Novick AC, Hsi ED et al. (1999). Dead or dying: necrosis versus apoptosis in caspase-deficient human renal cell carcinoma. Cancer Res 59: 2838-2842.
30. Kuwana T, Bouchier-Hayes L, Chipuk JE, Bonzon C, Sullivan BA, Green DR et al. (2005). BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. Mol Cell 17: 525-535.
31. Kuwana T, Mackey MR, Perkins G, Ellisman MH, Latterich M, Schneiter R et al. (2002). Bid, bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 111: 331-342.
32. Labi V, Erlacher M, Kiessling S, Villunger A. (2006). BH3-only proteins in cell death initiation, malignant disease and anticancer therapy. Cell Death Differ 13: 1325-1338.
33. Letai A, Bassik MC, Walensky LD, Sorcinelli MD, Weiler S, Korsmeyer SJ. (2002). Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2: 183-192.
34. Mickisch GH. (2002). Principles of nephrectomy for malignant disease. BJU Int 89: 488-495.
35. Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Rixe O et al. (2007). Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 356: 115-124.
36. Nakano K, Vousden KH. (2001). PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 7: 683-694.
37. O'Connor L, Strasser A, O'Reilly LA, Hausmann G, Adams JM, Cory S et al. (1998). Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J 17: 384-395.
38. O'Reilly LA, Cullen L, Visvader J, Lindeman GJ, Print C, Bath ML et al. (2000). The proapoptotic BH3-only protein bim is expressed in hematopoietic, epithelial, neuronal, and germ cells. Am J Pathol 157: 449-461.
39. Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T et al. (2000). Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288: 1053-1058.
40. Phillips JL, Ghadimi BM, Wangsa D, Padilla-Nash H, Worrell R, Hewitt S et al. (2001). Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease. Genes Chromosomes Cancer 31: 1-9.
41. Putcha GV, Moulder KL, Golden JP, Bouillet P, Adams JA, Strasser A et al. (2001). Induction of BIM, a proapoptotic BH3-only BCL-2 family member, is critical for neuronal apoptosis. Neuron 29: 615-628.
42. Puthalakath H, Huang DC, O'Reilly LA, King SM, Strasser A. (1999). The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol Cell 3: 287-296.
43. Puthalakath H, Strasser A. (2002). Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins. Cell Death Differ 9: 505-512.
44. Salvesen GS, Dixit VM. (1997). Caspases: intracellular signaling by proteolysis. Cell 91: 443-446.
45. Sturm I, Stephan C, Gillissen B, Siebert R, Janz M, Radetzki S et al. (2006). Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma. Cell Death Differ 13: 619-627.
46. Tan TT, Degenhardt K, Nelson DA, Beaudoin B, Nieves-Neira W, Bouillet P et al. (2005). Key roles of BIM-driven apoptosis in epithelial tumors and rational chemotherapy. Cancer Cell 7: 227-238.
47. Vaux DL, Hacker G, Strasser A. (1994). An evolutionary perspective on apoptosis. Cell 76: 777-779.
48. Villunger A, Michalak EM, Coultas L, Mullauer F, Bock G, Ausserlechner MJ et al. (2003). p53- and drug-induced apoptotic responses mediated by BH3-only proteins Puma and Noxa. Science 302: 1036-1038.
49. Wang X. (2001). The expanding role of mitochondria in apoptosis. Genes Dev 15: 2922-2933.
50. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ et al. (2001). Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292: 727-730.
51. Whitfield J, Neame SJ, Paquet L, Bernard O, Ham J. (2001). Dominant-negative c-Jun promotes neuronal survival by reducing BIM expression and inhibiting mitochondrial cytochrome c release. Neuron 29: 629-643.
52. Willis SN, Chen L, Dewson G, Wei A, Naik E, Fletcher JI et al. (2005). Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev 19: 1294-1305.
53. Zhu Y, Swanson BJ, Wang M, Hildeman DA, Schaefer BC, Liu X et al. (2004). Constitutive association of the proapoptotic protein Bim with Bcl-2-related proteins on mitochondria in T cells. Proc Natl Acad Sci USA 101: 7681-7686.